Drug firm Dishman Pharmaceuticals today said good manufacturing practice certificates of three sites of its arm Carbogen Amcis AG have been renewed by the Swiss regulator.
"The company's wholly owned subsidiary namely Carbogen Amcis AG, Switzerland has successfully completed the Swissmedic inspection...," Dishman Pharmaceuticals and Chemicals said in a BSE filing.
This has resulted in the renewal of the GMP-certificates, granted for its all three sites situated at - Bubendorf, Aarau and Neuland, it added.
Swissmedic is the Swiss authority for the licensing and monitoring of therapeutic products.
Disclaimer: No Business Standard Journalist was involved in creation of this content
